Auszug
Seit den ersten Avancen in den 80er-Jahren ergab sich ein erheblicher Modernisierungsschub in Strahlentherapie-, PET-Technik und Radiopharmazie. Unter den PET-Tracern dominiert aber auch hier in der Praxisdiagnostik immer noch das FDG, sieht man von den vielversprechenden Ansätzen der Radioimmun- und Molekulartherapie, z. B. mit 68Ga-Peptiden, ab.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bradley JD, Perez CA, Dehdashti F, Siegel BA (2004) Implementing biological target volumes in radiation treatment planning for non-small cell lung cancer. J Nucl Med 45:96–101
Buell U, Wieres FJ, Schneider W, Reinartz P (2004) 18FDG-PET in 733 consecutive patients with or without side-by-side CT evaluation (Analysis of 921 lesions). Nuklearmedizin 43:210–6
Coleman RE, Delbeke D, Guiberteau MJ et al. (2005) Concurrent PET/CT with an integrated imaging system:Intersociety dialogue from the joint working group of the American College of Radiology the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J Nucl Med 46:1225–39
Dietl B, Marienhagen J (2005) Der Einfluss der 18F-FDG-Ganzkörper-PET auf das therapeutische Management onkologischer Patienten aus strahlentherapeutischer Sicht. Nuklearmedizin 44:8–14
Gambhir SS, Czernin J, Schwimmer J et al. (2001) A tabulated summary of the FDG PET literature. J Nucl Med (Suppl) 42:1–93
Gärtner A (2005) Medizintechnik und Informationstechnologie 2, Bildmanagement. TÜV Media, Köln
Graham RN, Perriss RW, Scarsbrook AF (2005) DICOM demystified: A review of digital file formats and their use in radiological practice. Clin Radiol 60:1133–1140
Kabachinski J (2005) DICOM: key concepts — part II. Biomed Instrum Technol 39:292–294
Kabachinski J (2005) DICOM: key concepts — part I. Biomed Instrum Technol 39:214–216
Lucignani G, Jereczek-Fossa BA, Orecchia R (2004) The role of molecular imaging in precision radiotherapy for target definition, treatment planning optimisation and quality control. Eur J Nucl Mol Imaging 31:1059–1063
Noumeir R (2005) Benefits of the DICOM modality performed procedure step. J Digit Imaging 6
Rahn AN, Baum RP, Sengupta S et al. (1998) FDG PET in staging and therapy monitoring of esophageal cancer under radiotherapy. Eur J Nucl Med 25:145
Ratib O (2004) PET/CT image navigation and communication. J Nucl Med Suppl 1 45:46–45
Reubi JC, Körner M, Waser B et al. (2004) High expression of peptide receptors as a novel target in gastrointestinal stromal tumors. Eur J Nucl Med Mol Imaging 31:803–810
Riddle WR, Pickens DR (2005) Extracting data from a DICOM file. Med Phys 32:1537–1541
Schmücking M, Baum RP, Griesinger F et al. (2003) Molecular whole body cancer staging using positron emission tomography: Consequences for therapeutic management and metabolic radiation treatment planning. Recent Res Cancer Res 162:195–202
Weisser G, Walz M, Ruggiero S, Kammerer M, Schroter A, Runa A, Mildenberger P, Engelmann U (2005) Standardization of teleradiology using DICOM e-mail: recommendations of the German Radiology Society. Eur Radiol 15:1–6
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2006). Strahlentherapeutische Aspekte. In: PET/CT-Atlas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31215-3_14
Download citation
DOI: https://doi.org/10.1007/3-540-31215-3_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-31214-7
Online ISBN: 978-3-540-31215-4
eBook Packages: Medicine (German Language)